Gabin MWANDE-MAGUENE

Dr. Gabin MWANDE-MAGUENE

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GMGabin MWANDE-MAGUENE
Gabin MWANDE-MAGUENE
JJJouda Jakhlal
Jouda Jakhlal
MLMelissa Ladyman
Melissa Ladyman
AVAurélie Vallin
Aurélie Vallin
DRDimby Andrianina Ralambomanana
Dimby Andrianina Ralambomanana
LPLydie Pélinski
Lydie Pélinski

28 September 2011 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
GMGabin MWANDE-MAGUENE
Gabin MWANDE-MAGUENE
JJJouda Jakhlal
Jouda Jakhlal
JLJean-Bernard Lekana-Douki
Jean-Bernard Lekana-Douki
EMElisabeth Mouray
Elisabeth Mouray
TBTill Bousquet
Till Bousquet
LPLydie Pelinski
Lydie Pelinski
An efficient synthesis of 1,4-benzodiazepin-2-ones is described by condensation between 2-aminobenzophenone and Boc-protected amino acids via microwave-assisted irradiation. This produces higher yields in shorter reaction times than with traditional methods. The antiplasmodial activity of the corresponding ferrocenyl benzodiazepines was evaluated in vitro against Plasmodium falciparum F32 (chloroquine-sensitive) and FCB1 and K1 (chloroquine-resistant) strains and gabonese clinical isolates.

1 January 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GMGabin MWANDE-MAGUENE
Gabin MWANDE-MAGUENE
JLJean-Bernard Lekana-Douki
Jean-Bernard Lekana-Douki
EMElisabeth Mouray
Elisabeth Mouray
TBTill Bousquet
Till Bousquet
PGPhilippe Grellier
Philippe Grellier
LPLydie Pélinski
Lydie Pélinski

19 May 2021 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
MHMina Hariri
Mina Hariri
FDFatemeh Darvish
Fatemeh Darvish
KNKaren-Pacelye Mengue Me Ndong
Karen-Pacelye Mengue Me Ndong
NSNora Sechet
Nora Sechet
GCGeraud Chacktas
Geraud Chacktas
JPJean-Luc Michel Pirat
Jean-Luc Michel Pirat

30 August 2021 in GSC Biological and Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
MHMina Hariri
Mina Hariri
FDFatemeh Darvish
Fatemeh Darvish
KNKaren-Pacelye Mengue Me Ndong
Karen-Pacelye Mengue Me Ndong
RBRachida Babouri
Rachida Babouri
GMGabin MWANDE-MAGUENE
Gabin MWANDE-MAGUENE
JLJacques Lebibi
Jacques Lebibi
The present study aims to investigate the in vitro antibacterial activities of several isophosphinoline-2-oxides that can be perceived as combined bio isosteres of coumarins and flavonoids. More specifically, antibacterial activity was evaluated against four bacterial strains, including the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa and the Gram-positive bacteria Staphylococcus aureus and Enterococcus faecalis by using disk diffusion assay. Notably, isophosphinoline-2-oxide compounds showed promising and highly selective antimicrobial activity against S. aureus.

1 June 2021 in Heliyon
Verified
Journal Article
Open access
RBRalph Sydney Mboumba Bouassa
Ralph Sydney Mboumba Bouassa
BGBernard Gombert
Bernard Gombert
GMGabin MWANDE-MAGUENE
Gabin MWANDE-MAGUENE
AMAurèle Mannarini
Aurèle Mannarini
LBLaurent Bélec
Laurent Bélec
Zinc tetra-ascorbo-camphorate (or drug “C14”) is a synthetic monoterpenoid derivative that has potent anti-HIV-1 activity in vitro. In this study, we evaluated the in vitro antiviral properties of C14 against human papillomavirus (HPV). Inhibition assay of HPV-16-pseudovirus (PsVs) adsorption on COS-7 cells by C14 was used. C14 inhibited HPV-16-PsVs adsorption with IC50 ranging between 2.9 and 8.3 μM and therapeutic indexes between >410 to >3,300. Pretreatment of COS-7 cells with C14 before addition of HPV-16-PsV was associated with more potent anti-HPV activity than simultaneous deposition on COS-7 of HPV-16-PsV and C14, suggesting that C14 is more effective in preventing HPV attachment to target cells than post-HPV adsorption viral events. Overall, these in vitro studies suggest that the monoterpenoid zinc tetra-ascorbo-camphorate molecule may be suitable for further clinical evaluations as potential microbicide or therapeutic drug.